Oncological and reproductive outcomes of endometrial atypical hyperplasia and endometrial cancer patients undergoing conservative therapy with hysteroscopic resection: A systematic review and meta‐analysis
Acta Obstetricia et Gynecologica Scandinavica · 2024-08 · 103 (8) · 1498-1512
DOI: 10.1111/aogs.14815 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, online erschienen am 21.02.2024. Verfasst von Shuangshuang Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Hysteroscopy, Endometrial Hyperplasia, Conservative Treatment. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Anti-Cancer Association-Hengrui PARP Nicotinamide Cancer Research Fund, Tianjin Municipal Health Commission, National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Introduction
Our objective was to conduct a systematic review and meta‐analysis of studies evaluating the oncological and reproductive outcomes of patients with endometrial atypical hyperplasia (AH) and endometrioid endometrial cancer (EEC) undergoing conservative therapy with hysteroscopic resection (HR). Material and methods This study followed the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) statement for systematic reviews and meta‐analyses. The study strictly followed the methodological framework proposed by the Cochrane Handbook and was retrospectively registered in PROSPERO (CRD42023469986). Searches were conducted in PubMed, Embase, and the Cochrane Library, from inception to October 10, 2023. A checklist based on items of the Newcastle–Ottawa Scale and the Methodological Index for Non‐randomized Studies was used for quality assessment. The primary end points for this meta‐analysis were complete response (CR), pregnancy, and live birth rates following HR‐based therapy in patients with EEC or AH. The secondary end point was the recurrence rate (RR).
Results
Twenty‐one articles involving 407 patients with clinical stage IA, low or intermediate grade, EEC, and 444 patients with AH managed with HR‐based conservative treatment were included for this systematic review. CR to HR‐based conservative therapy was achieved in 88.6% of patients with EEC and 97.0% of patients with AH. Of these, 30.6% and 24.2%, respectively, had live births. The overall pooled disease RR was 18.3% and 10.8% in patients with EEC and AH, respectively. Further subset analyses revealed that EEC patients with body mass index (BMI) ≤28 kg/m 2 had higher CR rates as well as higher chances of pregnancy and live birth (91.6% CR, 32.9% pregnancy, 31.1% live birth) compared with patients with BMI >28 kg/m 2 (86.4% CR, 28.4% pregnancy, 23.0% live birth). The HR followed by oral progestogen subgroup had higher CR rates and higher chances of pregnancy and live birth (91.8% CR, 36.3% pregnancy, 28.2% live birth) than the HR followed by the levonorgestrel intrauterine system subgroup (82.5% CR, 25.3% pregnancy, 16.3% live birth).
Conclusions
Hysteroscopic resection followed by progestins appears to be a promising choice for fertility‐sparing treatment in young patients with AH and EEC, with effective and safe responses. The live birth rate remains to be improved by providing medical guidance and encouragement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China.
- Tianjin Key Laboratory of Female Reproductive Health and Eugenics, Tianjin Medical University General Hospital, Tianjin, China.
ORCID-Profile: Yingmei Wang
Förderung
- China Anti-Cancer Association-Hengrui PARP Nicotinamide Cancer Research Fund
- Tianjin Municipal Health Commission
- National Natural Science Foundation of China
- Key Technologies Research and Development Program
Zitieren
APA
Zhao, S., Zhang, J., Yan, Y., Tian, L., Chen, L., Zheng, X., Sun, Y., Tian, W., Xue, F., & Wang, Y. (2024). Oncological and reproductive outcomes of endometrial atypical hyperplasia and endometrial cancer patients undergoing conservative therapy with hysteroscopic resection: A systematic review and meta‐analysis. Acta Obstetricia et Gynecologica Scandinavica, 103(8), 1498-1512. https://doi.org/10.1111/aogs.14815
Vancouver
Zhao S, Zhang J, Yan Y, Tian L, Chen L, Zheng X, et al. Oncological and reproductive outcomes of endometrial atypical hyperplasia and endometrial cancer patients undergoing conservative therapy with hysteroscopic resection: A systematic review and meta‐analysis. Acta Obstetricia et Gynecologica Scandinavica. 2024;103(8):1498-1512. doi:10.1111/aogs.14815
BibTeX
@article{Zhao2024,
author = {Zhao, Shuangshuang and Zhang, Jingying and Yan, Ye and Tian, Lina and Chen, Lingli and Zheng, Xingyu and Sun, Yiqing and Tian, Wenyan and Xue, Fengxia and Wang, Yingmei},
title = {Oncological and reproductive outcomes of endometrial atypical hyperplasia and endometrial cancer patients undergoing conservative therapy with hysteroscopic resection: A systematic review and meta‐analysis},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2024},
volume = {103},
number = {8},
pages = {1498--1512},
doi = {10.1111/aogs.14815}
}
EUVIMED